Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography
We observed a strong association of C-Alb with CV risk in patients with no or mild CKD. This association was independent of traditional CV risk factors including eGFR and particularly strong regarding death due to congestive HF.
Authors
- Bernhard K. Krämer (ORCID: https://orcid.org/0000-0002-1718-2918)
- Anders Hayden Berg (ORCID: https://orcid.org/0000-0002-5736-0686)
- Christoph Wanner (ORCID: https://orcid.org/0000-0001-9507-5301)
- Graciela Delgado (ORCID: https://orcid.org/0000-0002-1272-7210)
- Christiane Drechsler (ORCID: https://orcid.org/0000-0002-0012-9707)
- Babak Yazdani (ORCID: https://orcid.org/0000-0001-9222-8958)
- Marcus E. Kleber (ORCID: https://orcid.org/0000-0003-0663-7275)
- Winfried März
Institutions
- Technische Hochschule Mannheim (DE)
- Cedars-Sinai Medical Center (US)
- Synlab Czech (Czechia) (CZ)
- University of Mannheim (DE)
- Medical University of Graz (AT)
- Heidelberg University (DE)
- University of Würzburg (DE)
- University Hospital Heidelberg (DE)
- Universitätsklinikum Würzburg (DE)
- Synlab (Germany) (DE)
- University Medical Centre Mannheim (DE)
- Heidelberg University (US)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2025-03-19
- DOI
- https://doi.org/10.1093/clinchem/hvaf021
- Citations
- 2
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- National Institutes of Health
- Seventh Framework Programme